Product Code: BIO236A
Highlights:
The global primary cells market should reach $1.9 billion by 2027 from $1.3 billion in 2022 at a compound annual growth rate (CAGR) of 9.0% for the forecast period of 2022 to 2027.
Human segment of the global primary cells market is expected to grow from $1.0 billion in 2022 to $1.6 billion in 2027 at a CAGR of 9.8% for the forecast period of 2022 to 2027.
Animal segment of the global primary cells market is expected to grow from $232.3 million in 2022 to $295.6 million in 2027 at a CAGR of 4.9% for the forecast period of 2022 to 2027.
Report Scope:
This report aims to provide a comprehensive study of the global market for primary cells, both in terms of quantitative and qualitative data, to help develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding primary cells. Segmentation is based on biological source type, tissue source type, application, end user, and region.
Industry growth drivers, restraints, trends, and opportunities in the primary cells market are also discussed in detail. The report also provides information on the competitive landscape, elaborative company profiles, and the impact of COVID-19 on the market.
Report Includes:
- 30 tables
- A comprehensive overview of the global market for primary cells
- Analyses of the global and regional market trends, with historic market revenue from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the upcoming market potential for primary cells, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size and revenue forecast for primary cells market in USD million terms, and corresponding market share analysis based on product type, product origin, application, end user, and region
- Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on manufacturers, suppliers, and major types of end users
- Identification of the companies that are best positioned to meet the demand for primary cells because of their proprietary technologies, strategic alliances, or other advantages
- Analysis of the vendor landscape based on their recent developments, financials, and segmental revenues
- Descriptive company profiles of the leading global players, including Charles River Laboratories, Lonza, Merck KGaA and Thermo Fisher Scientific
Table of Contents
Chapter 1 Introduction
- 1.1 Study Goals and Objectives
- 1.2 Reasons for Doing This Study
- 1.3 Scope of Report
- 1.4 Methodology Information Sources
- 1.5 Geographic Breakdown
- 1.6 Analyst's Credentials
- 1.7 BCC Custom Research
- 1.8 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
- 3.1 Cell
- 3.2 Cell Culture
- 3.3 Cell Lines
- 3.4 Primary Cells
- 3.5 Primary Cells vs. Cell Lines
- 3.6 Primary Cell Culture
- 3.6.1 Primary Cell Culture Media and Supplements
- 3.7 Characterization of Primary Cells
- 3.8 Primary Cell Culture Applications
Chapter 4 Market Dynamics
- 4.1 Market Drivers
- 4.1.1 Increasing Incidence of Chronic Diseases
- 4.1.2 Demand for Effective Drug Discovery and Development Process
- 4.1.3 Minimizing Animal Testing
- 4.1.4 Advances in Primary Cells Culture Technologies
- 4.1.5 Growing Spending on Pharmaceutical R&D
- 4.1.6 Strong Biotech Funding
- 4.1.7 Growing Applications in 3D Cell Culture Models
- 4.1.8 Growing Focus on Personalized Medicine
- 4.1.9 Growing Demand in Cell Therapy Research
- 4.2 Market Restraints
- 4.2.1 Demanding Requirements of Primary Cells
- 4.2.2 Donor Tissue Supply Issues
- 4.2.3 Ethical and Regulatory Concerns
- 4.3 Market Trends
- 4.3.1 Growing Demand for HLA-Typed Human Primary Cells
- 4.3.2 Impact of COVID- 19
Chapter 5 Market Breakdown by Biological Source Type
- 5.1 Introduction
- 5.1.1 Animal Primary Cells
- 5.1.2 Human Primary Cells
- 5.2 Global Market for Primary Cells by Biological Source
Chapter 6 Market Breakdown by Tissue Source Type
- 6.1 Primary Hematopoietic/Blood and Immune Cells
- 6.1.1 Overview
- 6.1.2 Hematopoietic Stem Cells (HSCs)
- 6.1.3 Applications
- 6.2 Primary Dermatocytes/Skin Cells
- 6.2.1 Overview
- 6.2.2 Applications
- 6.3 Gastrointestinal Cells
- 6.3.1 Overview
- 6.3.2 Applications
- 6.4 Primary Liver Cells/Hepatocytes
- 6.4.1 Overview
- 6.4.2 Applications
- 6.5 Primary Lung/Airway Cells
- 6.5.1 Overview
- 6.5.2 Applications
- 6.6 Renal/Kidney Cells
- 6.6.1 Overview
- 6.6.2 Applications
- 6.7 Primary Heart/Cardiac Cells
- 6.7.1 Overview
- 6.7.2 Applications
- 6.8 Musculoskeletal Cells
- 6.8.1 Overview
- 6.8.2 Applications
- 6.9 Other Primary Cells
- 6.9.1 Primary Brain Cells
- 6.9.2 Primary Brain Cells Applications
- 6.9.3 Other Primary Cells
- 6.10 Global Market for Primary Cells by Tissue Source Type
- 6.10.1 Primary Hematopoietic/Blood and Immune Cells
- 6.10.2 Primary Dermatocytes/Skin Cells
- 6.10.3 Primary Gastrointestinal Cells
- 6.10.4 Primary Liver Cells/Hepatocytes
- 6.10.5 Primary Lung/Airway Cells
- 6.10.6 Primary Renal/Kidney Cells
- 6.10.7 Primary Heart/Cardiac Cells
- 6.10.8 Primary Musculoskeletal Cells
- 6.10.9 Other Primary Cells
Chapter 7 Market Breakdown by End User
- 7.1 Overview
- 7.2 Global Market for Primary Cells by End User Type
- 7.2.1 Life Science Research Companies
- 7.3 Academic and Other Research Institutes
Chapter 8 Market Breakdown by Application
- 8.1 Overview
- 8.2 Basic Research
- 8.3 Drug Discovery
- 8.4 ADME, Toxicology and Safety Assessment Studies
- 8.4.1 ADME and Toxicology Studies
- 8.4.2 Safety Assessment Studies
- 8.5 Cell Therapy Research
- 8.5.1 Basic Research
- 8.5.2 Drug Discovery
- 8.5.3 Cell Therapy Research
Chapter 9 Market Breakdown by Region
- 9.1 Global Market for Primary Cells by Region
- 9.2 North America
- 9.2.1 Market Revenue, by Tissue Source Type
- 9.2.2 Market Revenue, by Country
- 9.3 Europe
- 9.3.1 Market Revenue by Tissue Source Type
- 9.3.2 Market Revenue, by Country
- 9.4 Asia-Pacific
- 9.4.1 Market Revenue by Tissue Source Type
- 9.5 Rest of the World (RoW)
- 9.5.1 RoW Primary Cells Market by Tissue Source Type
Chapter 10 Competitive Landscape
Chapter 11 Company Profiles
- AMERICAN TYPE CULTURE COLLECTION
- BIOIVT
- CELL APPLICATIONS INC.
- CELL BIOLOGICS
- CHARLES RIVER LABORATORIES
- DISCOVERY LIFE SCIENCES
- LIFENET HEALTH
- LONZA
- MERCK KGAA
- PELOBIOTECH GMBH
- PROMOCELL GMBH
- SCIENCELL RESEARCH LABORATORIES
- THERMO FISHER SCIENTIFIC INC.
- ZENBIO INC.